E-PILO 1 OPHTHALMIC SOLUTION 10 MG
EPINEPHRINE BITARTRATE : 10 MG PILOCARPINE HYDROCHLORIDE : 10 MG · DIN 02133180 · CIBA VISION CANADA INC
Health Canada status: CANCELLED POST MARKET
What is E-PILO 1 OPHTHALMIC SOLUTION?
E-PILO 1 OPHTHALMIC SOLUTION 10 MG contains EPINEPHRINE BITARTRATE : 10 MG PILOCARPINE HYDROCHLORIDE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02133180, held by CIBA VISION CANADA INC, supplied as DROPS for OPHTHALMIC administration. Health Canada currently lists it as cancelled post market, status dated 27-Jan-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02133180 |
|---|---|
| Brand name | E-PILO 1 OPHTHALMIC SOLUTION |
| Generic / active ingredient | EPINEPHRINE BITARTRATE : 10 MG PILOCARPINE HYDROCHLORIDE : 10 MG |
| Manufacturer | CIBA VISION CANADA INC |
| Strength | 10 MG |
| Dosage form | DROPS |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01EB51 PILOCARPINE, COMBINATIONS |
| AHFS class | 52:24.00 ; 52:40.20 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 27-Jan-1999 |
| Original market date | 1996-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S01EB51 PILOCARPINE, COMBINATIONS. 0 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| E-PILO 2 OPHTHALMIC SOLUTION | 20 MG | DROPS | CIBA VISION CANADA INC | CANCELLED POST MARKET | DIN 02133199 |
| E-PILO 4 OPHTHALMIC SOLUTION | 10 MG | DROPS | CIBA VISION CANADA INC | CANCELLED POST MARKET | DIN 02133202 |
| E-PILO 6 OPHTHALMIC SOLUTION | 10 MG | DROPS | CIBA VISION CANADA INC | CANCELLED POST MARKET | DIN 02133210 |
| E-PILO-1 OPH SOLN | 10 MG | DROPS | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00760021 |
| E-PILO-2 OPH SOLN | 10 MG | DROPS | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00759996 |
| E-PILO-4 OPH SOLN | 10 MG | DROPS | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00760013 |
| E-PILO-6 OPH SOLN | 60 MG | DROPS | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00760005 |
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.